Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Accolade, Inc. ACCD NASDAQ

NASDAQ Global Select • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
40/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$7.03
+0.1%

Accolade, Inc. (ACCD) is a Medical - Healthcare Information Services company in the Healthcare sector, currently trading at $7.02. It has a SharesGrow Score of 40/100, indicating a mixed investment profile with 1 out of 7 criteria passed.

Analyst consensus target is ACCD = $7 (+0.1% upside).

Financials: revenue is $414M, +37.7%/yr average growth. Net income is $100M (loss), growing at -112.7%/yr. Net profit margin is -24.1% (negative). Gross margin is 46.4% (+1.4 pp trend).

Balance sheet: total debt is $242M against $445M equity (Debt-to-Equity (D/E) ratio 0.54, moderate). Current ratio is 2.64 (strong liquidity). Debt-to-assets is 30.7%. Total assets: $788M.

Analyst outlook: 7 / 20 analysts rate ACCD as buy (35%) — mixed sentiment.

SharesGrow 7-Criteria breakdown: Value 50/100 (Partial), Growth 58/100 (Partial), Past 0/100 (Fail), Health 75/100 (Pass), Moat 53/100 (Partial), Future 34/100 (Fail), Income 10/100 (Fail).

$7.03
▲ 0.14% Upside
Average Price Target
The 12-month price target for Accolade, Inc. is $7.03.

ACCD SharesGrow Score Overview

47/100
SharesGrow Score
Mixed signals — some strengths
View full scorecard →
VALUE 50/100
Valuation — P/E, PEG, Forward PEG
GROWTH 58/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 75/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 53/100
Gross margin is + market cap
FUTURE 34/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — ACCD

~
VALUE Partial
50/100
ACCD trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Analyst consensus target is $7, implying -0.3% from the current price $7. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
~
GROWTH Partial
58/100
ACCD: +37.7%/yr revenue is, -112.7%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
✓
HEALTH Pass
75/100
Balance sheet ACCD: Debt-to-Equity (D/E) ratio 0.54 (moderate), Current ratio is 2.64 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
~
MOAT Partial
53/100
ACCD: Gross margin is 46.4% (+1.4 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 53/100. ≥ 70 = Pass.
View details →
✗
FUTURE Fail
34/100
Analyst outlook: 7 / 20 analysts rate ACCD as buy (35%). Analyst consensus target is $7 (-0.3% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
✗
INCOME Fail
10/100
ACCD: Net profit margin is -24.1%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range3.08-9.67
Volume4.54M
Avg Volume (30D)1.57M
Market Cap$575.59M
Beta (1Y)2.10
Share Statistics
EPS (TTM)-1.33
Shares Outstanding$74.91M
IPO Date2020-07-01
Employees2,400
CEORajeev Singh
Financial Highlights & Ratios
Revenue (TTM)$414.29M
Gross Profit$192.06M
EBITDA$-69.29M
Net Income$-99.81M
Operating Income$-114.45M
Total Cash$237.03M
Total Debt$241.65M
Net Debt$55.93M
Total Assets$788.15M
Price / Earnings (P/E)-5.3
Price / Sales (P/S)1.39
Analyst Forecast
1Y Price Target$7.03
Target High$7.03
Target Low$7.03
Upside+0.1%
Rating ConsensusHold
Analysts Covering20
Buy 35% Hold 65% Sell 0%
Price Target Summary
Company Info
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS00437E1029

Price Chart

Track all markets on TradingView
ACCD
Accolade, Inc. ↗  ·  NASDAQ Global Select
Healthcare • Medical - Healthcare Information Services
3.08 52WK RANGE 9.67

People Also View

RCM
RCM
R1 RCM Inc.
$14.31
+0.00%
 PRVA
PRVA
Privia Health Group, Inc.
$23.12
+0.48%
 PINC
PINC
Premier, Inc.
$28.26
+0.32%
 NXGN
NXGN
NextGen Healthcare, Inc.
$23.94
+0.13%
 AGTI
AGTI
Agiliti, Inc.
$10.05
-0.50%
 CERT
CERT
Certara, Inc.
$5.82
+0.52%
 HSTM
HSTM
HealthStream, Inc.
$20.34
-0.15%
 PHR
PHR
Phreesia, Inc.
$8.60
+0.47%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message